12-52839471-T-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_173352.4(KRT78):āc.1285A>Cā(p.Thr429Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000276 in 1,451,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_173352.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT78 | NM_173352.4 | c.1285A>C | p.Thr429Pro | missense_variant | 8/9 | ENST00000304620.5 | NP_775487.2 | |
KRT78 | NM_001300814.1 | c.955A>C | p.Thr319Pro | missense_variant | 8/9 | NP_001287743.1 | ||
KRT78 | XM_011538010.2 | c.1189A>C | p.Thr397Pro | missense_variant | 7/8 | XP_011536312.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT78 | ENST00000304620.5 | c.1285A>C | p.Thr429Pro | missense_variant | 8/9 | 1 | NM_173352.4 | ENSP00000306261.4 | ||
KRT78 | ENST00000359499.8 | c.955A>C | p.Thr319Pro | missense_variant | 8/9 | 1 | ENSP00000352479.4 | |||
KRT78 | ENST00000547920.1 | c.51-99A>C | intron_variant | 3 | ENSP00000448562.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000865 AC: 2AN: 231206Hom.: 0 AF XY: 0.0000160 AC XY: 2AN XY: 124750
GnomAD4 exome AF: 0.00000276 AC: 4AN: 1451618Hom.: 0 Cov.: 31 AF XY: 0.00000555 AC XY: 4AN XY: 721230
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at